These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial. Lydiatt WM; Bessette D; Schmid KK; Sayles H; Burke WJ JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):678-86. PubMed ID: 23788218 [TBL] [Abstract][Full Text] [Related]
6. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G; JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876 [TBL] [Abstract][Full Text] [Related]
7. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Lepola UM; Loft H; Reines EH Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155 [TBL] [Abstract][Full Text] [Related]
8. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC; JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833 [TBL] [Abstract][Full Text] [Related]
9. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Lenox-Smith AJ; Jiang Q Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525 [TBL] [Abstract][Full Text] [Related]
10. Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial. Kim JM; Stewart R; Lee YS; Lee HJ; Kim MC; Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Kim JH; Ahn Y; Jeong MH; Yoon JS JAMA; 2018 Jul; 320(4):350-358. PubMed ID: 30043065 [TBL] [Abstract][Full Text] [Related]
11. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Burke WJ; Gergel I; Bose A J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207 [TBL] [Abstract][Full Text] [Related]
12. Escitalopram : a review of its use in the management of major depressive and anxiety disorders. Waugh J; Goa KL CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392 [TBL] [Abstract][Full Text] [Related]
13. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694 [TBL] [Abstract][Full Text] [Related]
14. Escitalopram versus venlafaxine XR in the treatment of depression. Montgomery SA; Andersen HF Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901 [TBL] [Abstract][Full Text] [Related]
15. Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting. Foss-Nieradko B; Stepnowska M; Piotrowicz R Kardiol Pol; 2012; 70(6):591-7. PubMed ID: 22718378 [TBL] [Abstract][Full Text] [Related]
16. Trial of Psilocybin versus Escitalopram for Depression. Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780 [TBL] [Abstract][Full Text] [Related]
17. Depressive Symptoms in Stroke Patients: Are There Sex Differences? Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S Cerebrovasc Dis; 2020; 49(1):19-25. PubMed ID: 32023608 [TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128 [TBL] [Abstract][Full Text] [Related]
19. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. Stahl SM; Gergel I; Li D J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946 [TBL] [Abstract][Full Text] [Related]
20. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM; Llorca PM; Despiegel N; Verpillat P Encephale; 2004; 30(2):158-66. PubMed ID: 15107719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]